Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Delmar Pharmaceuticals Inc (DMPI)

Delmar Pharmaceuticals Inc (DMPI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3400 +0.0900 (+7.20%) 08/19/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3400 unch (unch) -
Quote Overview for Wed, Aug 19th, 2020
Day Low
1.1700
Day High
1.3500
Open 1.2200
Previous Close 1.2500 1.2500
Volume 1,331,400 1,331,400
Avg Vol 1,339,320 1,339,320
Stochastic %K 58.15% 58.15%
Weighted Alpha +156.40 +156.40
5-Day Change +0.1000 (+8.06%) +0.1000 (+8.06%)
52-Week Range 0.3800 - 1.5300 0.3800 - 1.5300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,318
  • Shares Outstanding, K 11,454
  • Annual Sales, $ 0 K
  • Annual Income, $ -8,050 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.53
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/08/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 1
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.89
  • Growth Rate Est. (year over year) +89.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8522 +57.24%
on 07/27/20
Period Open: 0.8800
1.5300 -12.42%
on 08/11/20
+0.4600 (+52.27%)
since 07/17/20
3-Month
0.6100 +119.67%
on 07/02/20
Period Open: 0.7010
1.5300 -12.42%
on 08/11/20
+0.6390 (+91.16%)
since 05/19/20
52-Week
0.3800 +252.63%
on 03/26/20
Period Open: 0.7750
1.5300 -12.42%
on 08/11/20
+0.5650 (+72.90%)
since 08/19/19

Business Summary

DelMar Pharmaceuticals, Inc. is involved in developing drug for orphan cancer indications. DelMar Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 1.4667
1st Resistance Point 1.4033
Last Price 1.3400
1st Support Level 1.2233
2nd Support Level 1.1067
3rd Support Level N/A

See More

52-Week High 1.5300
Last Price 1.3400
Fibonacci 61.8% 1.0907
Fibonacci 50% 0.9550
Fibonacci 38.2% 0.8193
52-Week Low 0.3800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective